Mad in America

DECEMBER 20, 2023

In Part 1 , we discussed Mad in America, the biopsychosocial model and the history of psychiatry. So even their self-judgment is not proof of the merits of the drugs, even for themselves, because they lack knowing what would have been possible for them. Whitaker: Yes, these fit in hand in glove. We don’t know.

Pharmaceuticals 144

Pharmaceuticals Aging and mental health Hospitality Biopsychosocial model 144

Mad in America

DECEMBER 13, 2023

You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. More aware of a need for humility.

Biopsychosocial model 139

Biopsychosocial model Pharmaceuticals Self-awareness Insurance 139

Mad in America

APRIL 30, 2025

When were you in medical school in the UK, were they teaching the DSM III disease model, or did you hear a different story about what causes depression? Moncrieff: When I was in medical school we were taught, as we’re still officially taught now, the biopsychosocial model of mental disorders.

Neurotransmitters and mental health 142

Neurotransmitters and mental health Pharmaceuticals Genetics and mental health Biopsychosocial model 142